Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.
about
Clinical Trial Accrual: Obstacles and OpportunitiesDisparities in Gynecological MalignanciesRole of aggressive surgical cytoreduction in advanced ovarian cancerFactors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study.Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.Ten Important Considerations for Ovarian Cancer ScreeningGene expression profiling of ovarian carcinomas and prognostic analysis of outcome.Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerThe care center influences the management of lymphoma patients in a universal health care system: an observational cohort studyIs It Time to Centralize Ovarian Cancer Care in the United States?Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.Complications from Surgeries Related to Ovarian Cancer Screening.Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival.Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States.Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.Values and worries of ovarian cancer patients.Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling.Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study.Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence.Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
P2860
Q26747284-A4E10DBE-D562-491E-893E-8F60216535EBQ26768263-902B8348-28D9-4EF7-8348-4EDEB9FF0BB7Q26801358-555BCC03-7A56-4F5F-92DC-2366CE0C835FQ33605208-3790976F-0C6C-4CFA-895E-7E8C2AB9BDFBQ33626973-D425BD32-C3FD-449B-A778-0A4D1A7A3CA0Q33639932-58DC74D5-0BF8-44B8-A2DA-1556BD9B4C1BQ33816983-99F0AC3E-1D2B-4C6C-947C-164271BD628AQ33850463-65D9ABC9-ED33-4C96-9D1D-C573B7A80893Q35906593-BBB5067F-E575-4869-AE94-2A8691A2C8AEQ36011137-F7D7E3DD-C2C8-41FE-B68D-71F0F3DE7898Q36093253-365514A9-C5FA-4BBD-B248-3384D13D6AF5Q36794300-D8B32B66-4B6E-49E1-AE71-D1C47AB24667Q37406838-FF9F4E2B-9019-4EAF-89AB-54ACE7526DCEQ37729985-C334C7CC-6F72-4516-A3CB-58B344C10344Q38857898-9FAFBDD0-FAA7-48A6-8FE5-4A2B52D67F15Q38861948-92B24B6E-1C10-4C1C-95AB-6B2FAC1D38A5Q38861953-6167E8E6-C482-45AA-BC7D-80D06A83E0FAQ39242605-48C2CB88-1219-4FA2-94F7-7DA986B69194Q40087667-7A86F9F4-3017-4842-BC7C-FDD53AC26B12Q47297885-D41FA16B-5FE5-44C7-BDCF-08AA080971DCQ47368363-DFCE7BE9-2C1C-41D3-B580-8F99182E261BQ47864518-6DBCCFAC-B572-4B1C-8377-114A56D18622Q49203345-08771DF1-CD4C-46E3-8473-04C5BE20DF26Q49887274-0A395F0C-B40D-413D-AD55-EEC0576A6C02Q53054061-E3CFFA52-F6C8-4C5F-ABE6-7209C3B74BA1Q55716532-FEE42914-6945-4C6A-8524-EA73384B53ED
P2860
Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Ovarian cancer in the United S ...... ciated with improved survival.
@ast
Ovarian cancer in the United S ...... ciated with improved survival.
@en
type
label
Ovarian cancer in the United S ...... ciated with improved survival.
@ast
Ovarian cancer in the United S ...... ciated with improved survival.
@en
prefLabel
Ovarian cancer in the United S ...... ciated with improved survival.
@ast
Ovarian cancer in the United S ...... ciated with improved survival.
@en
P2093
P2860
P1433
P1476
Ovarian cancer in the United S ...... ciated with improved survival.
@en
P2093
David G Mutch
J Philip Miller
Matthew A Powell
Noor Al-Hammadi
Phillip Y Roland
Robert E Bristow
William A Cliby
P2860
P356
10.1016/J.YGYNO.2014.10.023
P407
P577
2014-10-29T00:00:00Z